Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 47

Sort by

Sort Order Select

Journal Articles

The Upper Age Limit for a Pediatric-Inspired Therapy in Younger Adults with Ph-Negative Acute Lymphoblastic Leukemia (ALL)? Analysis of the Graall-2005 Study

Blood (2016) 128 (22): 762.

https://doi.org/10.1182/blood.V128.22.762.762

Published: 2016

Journal Articles

Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia

Blood (2014) 123 (24): 3739–3749.

https://doi.org/10.1182/blood-2014-01-547695

Published: 2014

Includes: Supplemental data

Journal Articles

Intensive Care Management and Outcomes In Allogeneic Hematopoietic Stem Cell Transplantation Recipients

Etienne Lengliné, MD, anne-Sophie Moreau, MD, Sylvie Chevret, MD, PhD, Frederic Pene, MD, PhD, François Blot, MD, Jean-Henri Bourhis, MD, Agnes Buzyn, MD, PhD, Benoît Schlemmer, MD, PhD, Gérard Socié, MD, PhD, Elie Azoulay, MD, PhD

Blood (2013) 122 (21): 4560.

https://doi.org/10.1182/blood.V122.21.4560.4560

Published: 2013

Journal Articles

Early posttransplantation donor-derived invariant natural killer T-cell recovery predicts the occurrence of acute graft-versus-host disease and overall survival

Marie-Thérèse Rubio, Lucia Moreira-Teixeira, Emmanuel Bachy, Marie Bouillié, Pierre Milpied, Tereza Coman, Felipe Suarez, Ambroise Marcais, David Sibon, Agnès Buzyn, Sophie Caillat-Zucman, Marina Cavazzana-Calvo, Bruno Varet, Michel Dy, Olivier Hermine, Maria Leite-de-Moraes

Blood (2012) 120 (10): 2144–2154.

https://doi.org/10.1182/blood-2012-01-404673

Published: 2012

Includes: Supplemental data

Journal Articles

Reduced Intensity Conditioning Regimens Do Not Offer a Survival Advantage to Myeloma Patients Receiving Allogeneic Stem Cell Hematopoietic Transplantation: A Societe Française De Greffe De Moelle Et De Therapie Cellulaire (SFGM-TC) Registry Study,

Yvan Beaussant, Etienne Daguindau, MD, Aurore Vivot, Mohamad Mothy, MD, PhD, Herve Avet-Loiseau, MD, PhD, Damien Roos-Weil, MD, Mauricette Michallet, Nicole Raus, Didier Blaise, MD, Stephane Vigouroux, MD, Agnes Buzyn, MD, PhD, Gérard Socié, Nathalie Fegueux, Frederic Garban, MD, PhD, Eric Deconinck, MD, PhD

Blood (2011) 118 (21): 4113.

https://doi.org/10.1182/blood.V118.21.4113.4113

Published: 2011

Journal Articles

Allogeneic Stem Cell Transplantation (allo-SCT) for Chronic Myelomonocytic Leukemia (CMML): Prognostic Factors for Survival. A Report From the Societe Francaise De Greffe De Moelle Et De Therapie Cellulaire (SFGM-TC),

Blood (2011) 118 (21): 3794.

https://doi.org/10.1182/blood.V118.21.3794.3794

Published: 2011

Journal Articles

Cost-Effectiveness of Double-Unit Cord Blood Transplantation Versus Single-Unit Cord Blood Transplantation in Adult Patients with Acute Leukaemia in France- On Behalf of SFGM-TC, Eurocord, ALWP-EBMT

Myriam Labopin, MD, MS, Annalisa Ruggeri, MD, Namik Taright, Federico Garnier, MD, Catherine Faucher, MD, Anne-Gaelle Le Coroller, Noel-Jean Milpied, MD, Didier Blaise, MD, Manuela Badoglio, Mohamad Mohty, Agnes Buzyn, Fernanda Volt, Eliane Gluckman, MD, PhD, Norbert C Gorin, Vanderson Rocha, MD, PhD

Blood (2011) 118 (21): 3130.

https://doi.org/10.1182/blood.V118.21.3130.3130

Published: 2011

Journal Articles

Pediatric-inspired intensified therapy of adult T-ALL reveals the favorable outcome of NOTCH1/FBXW7 mutations, but not of low ERG/BAALC expression: a GRAALL study

Blood (2011) 118 (19): 5099–5107.

https://doi.org/10.1182/blood-2011-02-334219

Published: 2011

Includes: Supplemental data

Journal Articles

Disease Status Is the Major Prognosis Factor for Allogenic Transplantation Outcome for Hodgkin Lymphoma: a Retrospective Study From the French Society of Bone Marrow Graft Transplantation and Cellular Therapy (SFGM-TC)

Blood (2010) 116 (21): 2359.

https://doi.org/10.1182/blood.V116.21.2359.2359

Published: 2010

Journal Articles

Phase II Prospective Multicenter Study of Treosulfan Based Reduced Intensity Conditioning In Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies From 10/10 HLA Identical Unrelated Donor

Mauricette Michallet, MD, PhD, Mohamad Sobh, Pharm.M., Stephane Morisset, Stat., Nathalie Tedone, CRA, Jacques-Olivier Bay, MD, PhD, Jean-Luc Harousseau, MD, PhD, Mohamad Mohty, Ibrahim Yakoub-Agha, MD, PhD, Agnes Buzyn, MD, PhD, Noel Milpied, MD, Franck E Nicolini, MD, PhD, Helene Labussiere, MD, Joachim Baumgart, PhD, Nicole Raus, Reza Tabrizi, MD, Didier Blaise, MD

Blood (2010) 116 (21): 2353.

https://doi.org/10.1182/blood.V116.21.2353.2353

Published: 2010

Journal Articles

Allogeneic Stem Cell Transplantation for Blast Crisis (BC) Chronic Myelogenous Leukemia (CML) In the Tyrosine Kinase Inhibitors (TKIs) Era. Analysis of Pre-Transplant Variables on Transplant Outcome. On Behalf of the Societe Française De Greffe De Moelle Et De Therapie Cellulaire and the French Group of CML

Blood (2010) 116 (21): 2266.

https://doi.org/10.1182/blood.V116.21.2266.2266

Published: 2010

Journal Articles

NOTCH1/FBXW7 Mutations, but Not Low ERG/BAALC Expression, Identify a Major Subgroup of Adult T-ALL with a Favorable Outcome: a GRAALL Study.

Raouf Ben Abdelali, MD, Agnes Buzyn, MD, PhD, Vahid Asnafi, MD, PhD, Sandrine Le Noir, PhD, Norbert Ifrah, MD, PhD, Herve Dombret, MD, PhD, Elizabeth Macintyre, MD, PhD

Blood (2009) 114 (22): 1568.

https://doi.org/10.1182/blood.V114.22.1568.1568

Published: 2009

Journal Articles

Impact of Genetic Abnormalities After Allogeneic Stem Cell Transplantation in Multiple Myeloma: Report of the Societe Francaise De Greffe De Moelle Et De Therapie Cellulaire.

Blood (2009) 114 (22): 1187.

https://doi.org/10.1182/blood.V114.22.1187.1187

Published: 2009

Journal Articles

Allogeneic Stem Cell Transplantation (allo-SCT) for Chronic Lymphocytic Leukemia: a Long Term Analysis From the Societe Francaise De Greffe De Moelle Et De Therapie Cellulaire (SFGM-TC).

Mohamad Mohty, MD, PhD, Jean-Paul Vernant, Ibrahim Yakoub-Agha, MD, PhD, Didier Blaise, MD, Gérard Socié, MD, Catherine Cordonnier, MD, Eric Deconinck, Jean-Henri Bourhis, François Guilhot, MD, Agnes Buzyn, Norbert Ifrah, MD, Denis Guyotat, MD, PhD, Jean-Luc Harousseau, Laurent Sutton, MD, Noel-Jean Milpied, MD, Mauricette Michallet, MD, PhD

Blood (2009) 114 (22): 201.

https://doi.org/10.1182/blood.V114.22.201.201

Published: 2009

Journal Articles

The Use of Bone Marrow Graft for Hematopoietic Stem Cell Transplantation From Matched Unrelated Donors After Reduced Intensity Conditioning Regimen Improves Survival : Analysis of the Societe Française De Greffe De Moelle Et De Therapie Cellulaire.

Andrea Toma, Marie-Lorraine Balère-Appert, Jean-Michel Boiron, MD, Pierre Bordigoni, Pr, Gerard Socie, MD, PhD, Jean-Paul Vernant, Pr, Marc Renaud, MD, Noel Milpied, MD, PhD, Mauricette Michallet, MD, PhD, Eric Deconinck, Pr, Denis Guyotat, MD, PhD, Frederic Garban, MD, Anne Sirvent, MD, Nathalie Contentin, MD, Didier Blaise, Pr, Evelyne Marry, Agnes Buzyn, Pr

Blood (2009) 114 (22): 873.

https://doi.org/10.1182/blood.V114.22.873.873

Published: 2009

Journal Articles

Long-Term Results of the Imatinib GRAAPH-2003 Study in Newly-Diagnosed Patients with De Novo Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia..

Blood (2009) 114 (22): 3080.

https://doi.org/10.1182/blood.V114.22.3080.3080

Published: 2009

Journal Articles

Safety and Efficacy of FLAMSA Regimen Followed by Allogeneic Hematopoietic Stem Cell Transplantation From Related and Unrelated Donors in High Risk Acute Leukemia and MDS Patients: A Study From the Societe Française De Greffe De Moelle Et De Therapie Cellulaire (SFGM-TC) Registry.

Blood (2009) 114 (22): 4335.

https://doi.org/10.1182/blood.V114.22.4335.4335

Published: 2009

Journal Articles

Reduced-Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) for Patients Aged ≥60 Years: a Retrospective Study of 629 Patients From the Societe Française De Greffe De Moelle Et De Therapie Cellulaire (SFGM-TC).

Blood (2009) 114 (22): 194.

https://doi.org/10.1182/blood.V114.22.194.194

Published: 2009

Journal Articles

Comparison of Outcomes After Allogeneic HSCT for Adult Patients with AML in Remission Using in the Conditioning Regimen Either I.V. Busulfex (BU) Plus Cyclophosphamide (Cy) or TBI Plus Cy: An- ALWP-EBMT Survey.

Arnon Nagler, MD, Myriam Labopin, Avichai Shimoni, Liisa Volin, Donald W. Bunjes, MD, PhD, Anne Huynh, Agnes Buzyn, Alessandro Rambaldi, Vanderson Rocha, MD, PhD

Blood (2009) 114 (22): 195.

https://doi.org/10.1182/blood.V114.22.195.195

Published: 2009

Journal Articles

NOTCH1/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) study

Blood (2009) 113 (17): 3918–3924.

https://doi.org/10.1182/blood-2008-10-184069

Published: 2009

Includes: Supplemental data

NARROW

The Upper Age Limit for a Pediatric-Inspired Therapy in Younger Adults with Ph-Negative Acute Lymphoblastic Leukemia (ALL)? Analysis of the Graall-2005 Study

Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia

Intensive Care Management and Outcomes In Allogeneic Hematopoietic Stem Cell Transplantation Recipients

Early posttransplantation donor-derived invariant natural killer T-cell recovery predicts the occurrence of acute graft-versus-host disease and overall survival

Reduced Intensity Conditioning Regimens Do Not Offer a Survival Advantage to Myeloma Patients Receiving Allogeneic Stem Cell Hematopoietic Transplantation: A Societe Française De Greffe De Moelle Et De Therapie Cellulaire (SFGM-TC) Registry Study,

Allogeneic Stem Cell Transplantation (allo-SCT) for Chronic Myelomonocytic Leukemia (CMML): Prognostic Factors for Survival. A Report From the Societe Francaise De Greffe De Moelle Et De Therapie Cellulaire (SFGM-TC),

Cost-Effectiveness of Double-Unit Cord Blood Transplantation Versus Single-Unit Cord Blood Transplantation in Adult Patients with Acute Leukaemia in France- On Behalf of SFGM-TC, Eurocord, ALWP-EBMT

Pediatric-inspired intensified therapy of adult T-ALL reveals the favorable outcome of NOTCH1/FBXW7 mutations, but not of low ERG/BAALC expression: a GRAALL study

Disease Status Is the Major Prognosis Factor for Allogenic Transplantation Outcome for Hodgkin Lymphoma: a Retrospective Study From the French Society of Bone Marrow Graft Transplantation and Cellular Therapy (SFGM-TC)

Phase II Prospective Multicenter Study of Treosulfan Based Reduced Intensity Conditioning In Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies From 10/10 HLA Identical Unrelated Donor

NOTCH1/FBXW7 Mutations, but Not Low ERG/BAALC Expression, Identify a Major Subgroup of Adult T-ALL with a Favorable Outcome: a GRAALL Study.

Impact of Genetic Abnormalities After Allogeneic Stem Cell Transplantation in Multiple Myeloma: Report of the Societe Francaise De Greffe De Moelle Et De Therapie Cellulaire.

Allogeneic Stem Cell Transplantation (allo-SCT) for Chronic Lymphocytic Leukemia: a Long Term Analysis From the Societe Francaise De Greffe De Moelle Et De Therapie Cellulaire (SFGM-TC).

The Use of Bone Marrow Graft for Hematopoietic Stem Cell Transplantation From Matched Unrelated Donors After Reduced Intensity Conditioning Regimen Improves Survival : Analysis of the Societe Française De Greffe De Moelle Et De Therapie Cellulaire.

Long-Term Results of the Imatinib GRAAPH-2003 Study in Newly-Diagnosed Patients with De Novo Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia..

Safety and Efficacy of FLAMSA Regimen Followed by Allogeneic Hematopoietic Stem Cell Transplantation From Related and Unrelated Donors in High Risk Acute Leukemia and MDS Patients: A Study From the Societe Française De Greffe De Moelle Et De Therapie Cellulaire (SFGM-TC) Registry.

Reduced-Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) for Patients Aged ≥60 Years: a Retrospective Study of 629 Patients From the Societe Française De Greffe De Moelle Et De Therapie Cellulaire (SFGM-TC).

Comparison of Outcomes After Allogeneic HSCT for Adult Patients with AML in Remission Using in the Conditioning Regimen Either I.V. Busulfex (BU) Plus Cyclophosphamide (Cy) or TBI Plus Cy: An- ALWP-EBMT Survey.

NOTCH1/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only